A pilot assay of interstitial photodynamic therapy with high-power laser system BioSpec® in a syngeneic breast cancer model

0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Photodynamic therapy (PDT) is a new technique that has already been applied to several types of cancer, which combines a photosensitizer, light and oxygen. Interstitial PDT is based on intra-tumor light delivery using laser fibers inserted via needle. In this work, the fiber TF-N09 and the high-power laser system BIOSPEC® were tested in a syngeneic breast cancer mouse model. Results obtained in this work indicates that the irradiation causes necrosis in both groups, a group treated with pre-photosensitizer and a non-treated group. Also, the maximum potency usable with this device was 500mW, since at a higher power the needle reached temperatures above 37 °C.

Cite

CITATION STYLE

APA

Araujo-Padilla, X., Delgado-López, M. G., Beltrán-Ortega, C., & Ramón-Gallegos, E. (2019). A pilot assay of interstitial photodynamic therapy with high-power laser system BioSpec® in a syngeneic breast cancer model. In AIP Conference Proceedings (Vol. 2090). American Institute of Physics Inc. https://doi.org/10.1063/1.5095904

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free